×

Access Whitepaper

First Name
Last Name
Company
Thank you!
Error - something went wrong!
   

Looking Ahead in 2019 Whitepaper

Seventeen senior WCG thought leaders share what they anticipate for the clinical research industry in 2019, and what everyone should be prepared for as we approach another year of change. 

About the Author

Dr. Lindsay McNair, MD, MPH, MSB | Chief Medical Officer, WCG

Dr. Lindsay McNair has extensive experience in the pharmaceutical industry. Prior to joining WCG, she was a consultant to pharmaceutical and biotechnology companies, providing medical guidance on clinical development strategies and study designs for new drug studies, and medical oversight of all phases of clinical trials. Dr. McNair teaches graduate-level courses on the scientific design of clinical research studies. She has been actively involved in IRB work for 18 years, and has a Master’s of Science in Bioethics with a concentration in research ethics.

Follow on Twitter Follow on Linkedin Visit Website More Content by Dr. Lindsay McNair, MD, MPH, MSB | Chief Medical Officer, WCG
Previous Flipbook
Invert to Convert: Rethinking Patient Recruitment and Enrollment Strategies
Invert to Convert: Rethinking Patient Recruitment and Enrollment Strategies

Next Flipbook
Addressing Suggestibility as a Psychological Phenomenon in Clinical Trials
Addressing Suggestibility as a Psychological Phenomenon in Clinical Trials

Request a Genetics in Clinical Trials training session

What You'll Learn